Zobrazeno 1 - 10
of 12
pro vyhledávání: '"33"'
Autor:
Wei J. Chen, Yao-Hsu Yang, Lin Yc, Pi-Hua Liu, Hsin-Hui Yu, Li-Chieh Wang, Jyh-Hong Lee, Bor-Luen Chiang
Publikováno v:
Lupus. 19:1219-1228
An imbalance between T Helper 1 (TH1) and T Helper 2 (TH2) cytokine production is important for the pathogenesis of systemic lupus erythematosus (SLE). We aimed to investigate gene—gene associations of TH1 and TH2 cytokines genes in Chinese patient
Publikováno v:
Langkilde, H, Voss, A, Heegaard, N & Laustrup, H 2017, ' Autoantibodies persist in relatives to systemic lupus erythematosus patients during 12 years follow-up ', Lupus, vol. 26, no. 7, pp. 723-728 . https://doi.org/10.1177/0961203316676378
Background Systemic lupus erythematosus (SLE) is an autoimmune disease with presence of autoantibodies and characteristic multi-organ involvement. Relatives of SLE patients have an increased risk of autoantibody production and autoimmune diseases. Me
Autor:
Shaghayegh Habibi, Saeedeh Shenavandeh
Publikováno v:
Lupus. 26(9)
Introduction The clinical expression of systemic lupus erythematosus (SLE) is the consequence of endothelial cell damage leading to serious multiple organ dysfunction. The aim of this study was to assess the association between nailfold capillaroscop
Publikováno v:
Lupus. 18:713-717
The aim of this article is to compare the prevalence of anti-cyclic citrullinated peptide (anti-CCP) antibodies in systemic lupus erythematosus (SLE) patients with and without arthritis and in patients with rheumatoid arthritis (RA). Anti-CCP antibod
Publikováno v:
Lupus. 13:36-44
The objective of this paper is to investigate the association between patterns of anti-dsDNA antibody isotypes and specific clinical manifestations (categorized in renal, musculoskeletal, cutaneous, hematological, pulmonary, neurologicaland cardiac).
Autor:
Omer Karadag, Yahya Buyukasik, Ali Akdogan, Levent Kilic, Sedat Kiraz, İsmail Doğan, Umit Akman, Şule Apraş Bilgen, Ihsan Ertenli
Publikováno v:
Lupus. 22(8)
Systemic lupus erythematosus (SLE) patients are at increased risk of thrombosis and cardiovascular diseases. Aspirin is an effective treatment option for these patients. The aim of this study was to investigate the presence of aspirin resistance in S
Autor:
Hung-Chieh Yeh, Chiu-Ching Huang, Hsin-Hung Lin, Tzung-Hai Yen, Chih-Chia Liang, Jiung-Hsiun Liu, I-Kuan Wang, Chiz-Tzung Chang, Huey-Liang Kuo, Cheng-Chieh Hung
Publikováno v:
Lupus. 19(10)
Objective: Although there have been many studies on systemic lupus erythematosus (SLE) patients, there are few data about survival analysis of lupus patients receiving dialysis. Therefore, the objective of this study is to analyze risk factors predic
Autor:
A.J. Chamorro, Jordi Yagüe, J C Botero, Miguel Ingelmo, S Segura, Ricard Cervera, Manuel Ramos-Casals, Josep Font, G Salvador, M T Campoamor
Publikováno v:
Lupus. 13(10)
The objective of the study was to analyse the prevalence and clinical significance of hypocomplementemia in a large series of patients diagnosed either with systemic lupus erythematosus (SLE) or with primary antiphospholipid syndrome (APS) and its as
Publikováno v:
Lupus. 13(1)
The objective of this study was to determine the expression and activity of CTLA4 in T-cells of systemic lupus erythematosus (SLE) patients. Expression of CTLA4 on freshly isolated peripheral blood T-cells was evaluated in 33 SLE patients and 25 cont
Autor:
Stefano Bombardieri, Walter Bencivelli, Rossella Neri, R Puccini, S Giannessi, A. Pasquariello, Marta Mosca
Publikováno v:
Lupus. 10(4)
The incidence of renal flares and the long-term outcome in a group of 33 systemic lupus erythematosus (SLE) patients with diffuse proliferative glomerulonephritis (DPGN) treated with pulse steroids and a short course of pulse cyclophosphamide (CYC) a